June 17, 2020 -- NanoString Technologies has debuted new products that advance COVID-19 research by studying the immune response of the SARS-CoV-2 virus.
The company's nCounter host response gene expression panel and COVID-19 panel plus spike-in provide comprehensive analyses of the viral infection and immune response. New protein and RNA content available on the GeoMx digital spatial profiler enables analysis of key biological pathways mapped to specific regions within infected tissues, according to NanoString.
The company demonstrated at the LabRoots Coronavirus Virtual Conference on June 17 that applying these new tools in SARS-CoV-2 formalin-fixed paraffin-embedded (FFPE) tissue samples helped better understand the processes underlying infection, pathogenesis, and therapeutic response.